Novartis' (NVS) CEO Joseph Jimenez on Q4 2016 Results - Earnings Call Transcript

Jan. 26, 2017 11:45 AM ETNovartis AG (NVS)
SA Transcripts profile picture
SA Transcripts
133.96K Followers

Novartis AG (NYSE:NVS) Q4 2016 Earnings Conference Call January 25, 2017 7:00 AM ET

Executives

Vasant Narasimhan - CMO

Samir Shah - Global Head of IR

Harry Kirsch - CFO

Mike Ball - CEO of Alcon

Paul Hudson - CEO, Novartis Pharmaceuticals

Joseph Jimenez - CEO

Bruno Strigini - CEO of Novartis Oncology

Jay Bradner - President of NIBR

Analysts

Michael Oustin - UBS

Mary Evan-Lewis - Prime Avenue

Manoj Garg - Healthco

Vasant Vasa - JPMorgan

Vincent Manye - Morgan Stanley

Michael Leecoat - Main First

Narif Strahan - New Street

Richard Vosser - JPMorgan

Michael Dion - UBS

Naresh Chouhan - New Street

Richard Wagner - Bernstein

Joseph Jimenez

I'd like to welcome our webcast audience. We're webcasting this for the first time and so we'll be happy to take questions as we get into Q&A, both from the audience here and also from the webcast, so feel free to send in your questions. Now before we get started, I would like Samir to read the Safe Harbor Statement.

Samir Shah

Sure. Good afternoon, everybody. The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties and other factors. These may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Please refer to the Company's form 20-F on file with the U.S. Securities and Exchange Commission for a description of some of these factors.

Joseph Jimenez

Thanks, Samir. Okay, we've got a pretty interesting agenda today. Harry and I are going to talk through 2016 results and the plans for 2017. Then we've got Paul Hudson coming up you to talk about the pharmaceuticals business. Mike Ball will give an update on Alcon. And then you're in for a real treat as Vas and Jay take us deep into the pipeline

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.